Website
N/ATelephone
N/A
Address
Description
CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. The company was founded in September 2022 and is headquartered in Hatfield, PA.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.09 - 0.28
Trade Value (12mth)
AU$9,205.00
1 week
5%
1 month
10.53%
YTD
-25%
1 year
-41.28%
All time high
0.53
EPS 3 yr Growth
N/A
EBITDA Margin
-323.40%
Operating Cashflow
-$22m
Free Cash Flow Return
-57.50%
ROIC
-60.80%
Interest Coverage
-12.80
Quick Ratio
1.50
Shares on Issue (Fully Dilluted)
363m
HALO Sector
Healthcare
Next Company Report Date
20-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
30 April 25 |
Quarterly Appendix 4C Cash Flow Report
×
Quarterly Appendix 4C Cash Flow Report |
30 April 25 |
Quarterly Activity Report - Q3 FY25
×
Quarterly Activity Report - Q3 FY25 |
30 April 25 |
Investor Presentation - Q3 FY25 Quarterly Update
×
Investor Presentation - Q3 FY25 Quarterly Update |
24 April 25 |
Timing of Q3 Quarterly Results Release & Webinar
×
Timing of Q3 Quarterly Results Release & Webinar |
09 April 25 |
Application for quotation of securities - CVB
×
Application for quotation of securities - CVB |
08 April 25 |
CVB expects no material adverse effects from US tariffs
×
CVB expects no material adverse effects from US tariffs |
07 April 25 |
Notification of cessation of securities - CVB
×
Notification of cessation of securities - CVB |
04 April 25 |
Change of Director's Interest Notice - Rob Lilley
×
Change of Director's Interest Notice - Rob Lilley |
04 April 25 |
Change of Director's Interest Notice - Arun Singh
×
Change of Director's Interest Notice - Arun Singh |
03 April 25 |
Application for quotation of securities - CVB
×
Application for quotation of securities - CVB |
31 March 25 |
Vendor Validation of Enhanced HiRise in Final Stages
×
Vendor Validation of Enhanced HiRise in Final Stages |
25 March 25 |
Notification of cessation of securities - CVB
×
Notification of cessation of securities - CVB |
20 March 25 |
Presentation at NWR Healthcare Conference
×
Presentation at NWR Healthcare Conference |
28 February 25 |
Appendix 4D - Interim Financial Report - Dec 2024 Half Year
×
Appendix 4D - Interim Financial Report - Dec 2024 Half Year |
28 February 25 |
CVB - Commentary to App 4D - Dec 24 Half Year
×
CVB - Commentary to App 4D - Dec 24 Half Year |
04 February 25 |
Presentation at Euroz Hartleys 2025 Healthcare Forum
×
Presentation at Euroz Hartleys 2025 Healthcare Forum |
29 January 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
29 January 25 |
Investor Presentation - Q2 FY25 Quarterly Update
×
Investor Presentation - Q2 FY25 Quarterly Update |
28 January 25 |
Commercial Agreement with Stryker expanded to Aust & NZ
×
Commercial Agreement with Stryker expanded to Aust & NZ |
21 January 25 |
Timing of Q2 Quarterly Results Investor Webinar
×
Timing of Q2 Quarterly Results Investor Webinar |
19 December 24 |
Ceasing to be a substantial holder - Greg Brown
×
Ceasing to be a substantial holder - Greg Brown |
19 December 24 |
Change in substantial holding - CVB in itself
×
Change in substantial holding - CVB in itself |
16 December 24 |
Notification regarding unquoted securities - CVB
×
Notification regarding unquoted securities - CVB |
16 December 24 |
Notification regarding unquoted securities - CVB
×
Notification regarding unquoted securities - CVB |
16 December 24 |
Change of Director's Interest Notice - Greg Brown
×
Change of Director's Interest Notice - Greg Brown |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.